What Happened?
Philadelphia, PA-based Carisma-Therapeutics Appointed Steven Kelly as President and Chief Executive Officer
About the Company
Carisma Therapeutics is pioneering the development of CAR macrophages, a disruptive approach to immunotherapy. Our technology leverages advances in macrophage biology, chimeric antigen receptor engineering and adoptive cellular therapy for the treatment of human disease.
About the Person
Steven Kelly is President and Chief Executive Officer at Carisma Therapeutics. Previously, Steven held various senior HR leadership roles in the industry.
Info Source
News
Short Profile